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A SCARCrTY of information exists in the literature on the hepatocareinogenic
effects of combinations of azo dyes, similar to the competition in epithelial carci-
nogenesis betweenpolycyclic.hydrocarbons as described firstbyLacassagne, Buu-
Hoi and Rudali (1945). In the reports available on synergism among azo carcino-
gens only the synergistic effect of 4-dimethylaminoazobenzene (DAB) and 4'-
methyl-DAB has been confirmed (MacDonald et al., 1952; Corre-Hurst et al.,
1953). The final assessment of the synergism between DAB and 3'-methyl-DAB
(3'-Me-DAB) described in the 1953 report will require further experiments, how-
ever, in view of the fact that the authors found a higher tumor incidence with
DAB than with 3'-Me-DAB, which is the inverse ofthegenerallyaccepted relative
carcinogenicites of the two compounds. Inhibitory effect among azo carcinogens
has been reported by Crabtree (1955) who described inhibition of DAB induced
hepatic tumorigenesis by certain non-carcinogenic derivatives of azobenzene.
These observations have now been extended by studying the carcinogenic
effect of dietary mixtures of the potent hepatic carcinogen, 3'-Me-DAB, of its
relatively inactive isomer, 2-Me-DAB, and of the parent compound DAB. This
report describes the synergistic effect of 3'-Me-DAB and of 2-Me-DAB when these
dyes are present in a. 1 : 2 proportion in the diet. However, when these two azo
compounds are present in a ratio of I : 1, the synergistic effect is -abolished, and
the comparison ofthe tumor incidences may be considered suggestive of a limited
inhibitory effect of 2-Me-DAB on 3'-Me-DAB tumorigenesis. In relation to this
biological effect the phase diagram of 2-Me and 3'-Me-DAB has been studied to
bring evidence for their actual similarity of spatial configuration.
MATERIALS AND METHODS
Care and feeding of animals.-Sprague-Dawley male rats, weighing 180 to
230 g. at the beginning of the experiment and housed two to a cage, were used.
The rats were fed a semi-synthetic diet, called hereafter basal diet, similar to the
diet No. 2 used by Miller, Miller and Finger (1957). In the present diet, however,
theprevious salt mixture(Miller, MacDonald andAUller, 1955) hasbeen substituted
by the commercially available Salt Mixture W (Nutritional Biochemicals Corpor-
ation, Cleveland 28, Ohio). In addition to this, the diet was now supplemented
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with 1-6 mg.,,kg. of Menadione (2-methyl-1,4-naphthoquinone) and also with
14 mg.,,'kg. of zinc sulfate heptahydrate since the Salt mixture W does not contain
zinc, which is essential to the development of the rat (Farris and Griffith, 1949).
The azo compounds, DAB, 3'-Me-DAB and 2-Me-DAB were incorporated in the
basal diet at the levels stated in Table I. The r,-.ts were fed basal diet for at least
TABLEI.-Hepatic Tumour Incidence with Combination-s of
3'-Me-DAB, 2-Me-DAB and DAB
Incidence of liver tumors*
Number (months of continuous feeding)
of rats (_ _k..
Groul) Diet started 31 4 41 6 7 8
A 0-02 per cent 3'-Me-DAB + 23 0/20 5/20t
0-04 per cent 2-Me-DAB
B 0-02 per cent 3'-Me-DAB 23 0/23 1/23
C 0-04 per cent 2-Me-DAB 223 0/23 0/22
D 0-0,2115 per cent 3'-Me-DAB + 24 1/241 - 10/24 21/23
0-035 per cent 2-Me-DAB
E 0-035 per cent 3'-Me-DAB 24 0/24 - 14/24 24/24
F 0-06 per cent 2-Me-DAB 3 20 - 1/18 4/17
mo. ---> 0-054 per cent DAB
G Basal diet 3 mo. --> 0-054 per 20 0/20 3/18
cent DAB
Number of rats with tumors/number of rats alive.
In addition to these five tumor bearing animals, a sixth had a teratoi-na of a kidney.
+ Hepatic tumors failed to develop in an additional group of 19 rats maintained on this diet for
3.1, iiionths. This would bring the overall tumor incidence to 1/43.
1 week prior to the feeding of the dye containing diet. All diets and water were
ad libitum. For the intermittent examinations for liver tumors exploratory
laparotomy was performed under ether anesthesia. At the end of the respective
experiments all survivors were sacrificed for final tumor count and extensive
autopsy. Allmacroscopically visible nodules foundduringexploratorylaparotomy
or at the termination of experiments were examined histopathologically. When
no gross tumor was apparent and no small tumor foci were visible, the liver was
described as
"' normal
" regardless of the well known cellular changes preceding
the emergence of tumors, which was the criterion used by Crabtree (1955).
Preparation of compounds ard determination of pha-se diagram8.-DAB was
obtained commercially. 3'-w_e--__DAB and 2-Me-DAB were prepared in our labo-
ratory following the standardized procedure of Miller, Sapp and Miller (1949).
4-Hydroxyazobenzene was obtained in a similar way by coupling benzenedia-
zonium-chloride to phenol in 70 per cent aqueous ethanol in the presence of 1-5
mole NaOH for each mole ofphenol. At the end ofcoupling, the reaction mixture
was brought to pH 7 and the precipitation of the dye enhanced by adding a satu-
rated solution of sodium acetate.
Once crystallized samples were used for feeding, and three times crystallized
and carefully driedsamples were used for the determination ofthepbase diagrams.
Initial thawing points and final melting points were taken in triplicate with a
capillary arrangement in a Thiele tube fitted with a standardized thermonieter
and a magnifying lens. All melting points are corrected. The variations of the
final melting points were within ±0-5 per cent.-)(')'I ,.d , " SYNERGISM IN AZO-DYE CARCINOGENESIS
RESULTS ALND DISCUSSION
Animal experiment8
The tumor incidences given for Groups A, B and C of Table I show marked
synergism when 0-04 per cent 2-Me-DAB and 0-02 per cent 3'-Me-DAB are present
in mixture in the diet fed for 7 inonths. That the observed effect corresponds to
true synergism is indicated by the fact that in Group A the two compounds to-
gether (at the concentrations as they are present singly in Groups B and C) pro-
duced 5 tumor bearers in 20 rats (25 per cent incidence), compared with I tumor
bearer produced by these dyes administered separately to a total of 45 rats in
Cxroups B and C (2-2 per cent). This difference is statistically significant, since
P < 0-01using Fisher's exact test for 2 x 2 contingency tables. On the other
hand, a comparison ofGroups C, D and E indicates that when these two dyes are
present in the diet in equal proportion, no synergism is observed although the
level of 2-Me-DAB in the test Group D (0-035 per cent) is similar to that in test
Group A (0-04 per cent). For the difference between the tumor incidences in
Groups C plus E, and Group D, at 41 monthsX2
-_ 0-545 was found, corresponding 2
to P - 0
-45 on I degree of freedom.
Two alternative assumptions may be made for the absence of synergism in the
latter experiment : (1) If the tumor incidence values in these various groups are
plotted against the respective time intervals, it may be seen that the slope of the
curve of Group E is much greater than the one of the synergistic Group A. For
this reason the absence of synergism in Group D may be interpreted as resulting
from a
" covering
" of the synergistic effect of 0-035 per cent 2-Me-DAB by the
rapidity of tumour development due to the presence of 3'-Me-DAB at the 0-0315
per cent level. (2) When both 2-Me and 3'-Me-DAB are fed at identical levels of
0-035 per cent each (Group D), competitive antagonism may occiir at certain
cellular binding sites compensating the synergistic effect of 2-Me-DAB. This
possibility of competitive antagonism is also suggested by : (a) the presence of
both compounds in all liver cell fractions of treated rats (Price et al., 1949, 1950 ;
Hultin, 1956) ; (b) the closesimilarityofthespatial configurations of the two dyes
(see
" Phase Diagrams "), and (c) the fact that both 2-Me and 3'-Me-DAB are
linked in the soluble cytoplasm to the same electrophoretic protein fraction (Sorof
et al., 1951 ; Wirtz and Arcos, 1958). The comparison of the tumor incidences at
41 months in Group D (10/24) and Group E (14/24) may actually be considered as 2
suggestive of a limited inhibition of 3'-Me-DAB tumorigenesis by 2-Me-DAB. The
statistical significance of this apparent difference is, however, low (P
- 0-30).
Unfortunately, due to the difficulties incarrying outlarge numbers oflaparotomies
within short intervals oftime and because theseexperiments had to be terminated,
a more solid assessment of the latter data could not be obtained.
In another experiment, feeding of 2-Me-DAB preceeded feediiig the medium
active DAB (Groups F and G). The rats of the test Group F were fed 0
- 06 per
cent 2-Me-DAB for 3 months, which has been shown (Miller and Miller, 1947) to
be the time when maximum level of bound dye is reached with this compound
under similar dietary conditions. After this period, feeding was immediately
continued with 0-054 per cent DAB. The control Group G was fed basal diet for
3 months and then fed the same level of DAB. No difference could be observed
between the tumorincidences inthesegroups (P > 0-90). Thus,previous saturation
ofcellularbinding sites with 2-Me-DAB does not affect DAB inducedtumorigenesis.
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FIG. I to 5.-Phase diagrams ofbinary mixtures of azo dyes showingpolymorphic transforma-
tions and regions of continuous miscibility. Final melting points (solid line) varied within
±0-5 per cent. The dotted line curves give the initial thawing points. The figures cor-
respond to the foRowing pairs ofcompounds: Fig. 1, 3'-Me-DAB plus 2-Me-DAB; Fig. 2,
DAB plus 4-hydroxyazobenzene; Fig. 3, 3'-Me-DAB plus 4-hydroxyazobenzene; Fig. 4,
DAB plus 2-Me-DAB; Fig. 5, 3'-Me-DAB plus 20-methylcholanthrene.
Histologically the tumors were classified mainly as hepatomas and cholangio-
carcinomas and these two histopathological types were observed in about equal
proportion. Three ofthe 5 tumors found inGroup A fed 0-04 per cent 2-Me-DAB
plus 0
-02 per cent 3'-Me-DAB were, however, cholangiomas.
The cellular mechanism that may account for the observed synergistic effect
must involve more than one receptor site (cf. Ariens, van Rossum and Simonis,
1956 ; Veldstra, 1956) and this is consistentwiththegeneral distribution ofbound,
aminoazo dyes among all cell components of the liver (Price et al., 1949, 1950;
Hultin, 1956). The liver enzyme systems which metaboHze various drugs and
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and ring hydroxylation (e.g., Mueller and Miller, 1949; Conney et al., 1957 ;
Conney, Miller and Miller, 1957 ; Conney et al., 1959) have been identified in the
microsome
" fraction. These enzyme systems are altered and functionally
eliminated at high levels of feeding 3'-Me-DAB (Miller, Miller and Brown, 1952)
at a rate which may be expected to be linear with the concentration of the dye
fed. An approximate proportionality is in fact shown by thecarcinogenicifies of
0-06 per cent and 0-035 per cent 3'-Me-DAB diets : 100 per cent tumour incidence
has been observed in a group of 16 rats after 4 months of continuous feeding 0-06
per cent 3'-Me-DAB, while Table I indicates that with 0-035 per cent diet only
14 tumour bearing rats out of 24 have been found after 41 months (Group E).
This approximate linearity ofthe dose-response fails, however, when the responses
to the 0-035 and 0-02 per cent diets are compared, since no tumor bearing animal
is found when the latter diet is fed for 41 months to 23 rats (Group B). The relative
inactivity of the 0-02 per cent 3'-Me-DAB diet may be due to a rate of metabolic
inactivation whichbalances the rate ofarrival ofthedye in the liver. Consequently,
from the standpoint of the process of carcinogenesis, the microsomal enzyme
systems inactivating 3'-Me-DAB may be considered
" sites of loss
" in the sense
described by Veldstra (1956).
Careinogenesis may result then from : (a) intake of 3'-Me-DAB in excess over
the metabolic capacity of the enzyme systems in the microsomes, which excess
will be available for alteration ofthis cellorganelle proper (Arcos and Arcos, 1958 ;
Porter and Bruni, 1959), and of other cellular components, e.g. the mitochondria
(Arcos, Griffith and Cunningham, 1960), at a rate which is proportional to the
amount of non-metabolized dye, such as may be the case with the 0-035 and 0-06
per cent diets, or (b) competition of 2-Me and 3'-Me-DAB at
" sites of loss
" (cf.
Veldstra, 1956) making 3'-Me-DAB available at other cellular sites the alterations
of which are involved in the succession of steps leading to careinogenesis (Arcos,
Gosch and Zickafoose, 1961).
Pha8e diagraM8
Synergism and antagonism as the response to simultaneously present bio-
logically active compounds often involves close steric molecular similarity (e.y.
A'eldstra, 1956). Because of steric hindrance between the 2-methyl group and the
a-azo nitrogen in 2-Me-DAB (Arcos and Arcos, 1958), it may be expected that
the spatial configuration of this compound and of 3'-Me-DAB may not be so
closely similar as suggested by the simple observation of the structural formulae.
Steric hindrance in 2-Me-DAB is also suggested by the high basicity of the amino
nitrogen (Cilento, 1960), because of interference with the resonance involving the
azo double boiid and consequent increase of the electron density at the amino
nitrogen. For these reasons, the phase diagram of these dyes, and comparatively
ofbinary mixtures ofother azocompounds have been studied since it is well known
that polymorphic transformations or continuous mixed crystal formation, that
may be detected in such diagrams, indicate interchangeability in mixed crystal
lattices (e.g. Eitel, 1945) which in turn is dependent on close steric similarity or
complementarity (e.g. Timmermans, 1939 ; Fredga, 1945).
The phase diagrams obtained with mixtures of various azo dyes suggest that
the interchangeability of 3'-Me-DAB and 2-Me-DAB in their mixed crystal lattices
is relatively higher than in mixed crystals of certain structurally related azo dyes.
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of at least four regions of polymorphic transformations, in addition to a rather
flat eutectic region around 90 per cent 2-Me-DAB. Moreover, the flatness of this
region and the even concavity of the thawing point curve (dotted line) relatively
to the final melting point curve (solid line) is suggestive, that other polymorphic transformations might have remained undetected and so that the two compounds possibly form a nearly continuous series of solid solutions. The temperature dif-
ferences involved in the regions of polymorphic transformations are significant because of the narrow range of the final melting points (±0-5 per cent). Thus,
there is no overlapping between the minima representing these polymorphic transformations and the points (with the respective ±0-5 per cent ranges) cor-
responding to them on a curve which would join the remaining points of the final
melting point curves. Decreasing numbers oi polymorphic transformations may be obserATed in the phase diagrams of other azo dyes (Fig. 2 to 5). However, the
curve of the thawing points in Fig. 4 is suggestive that, also with DAB plus 2-Me-
DAB, other regions of polymorphic transformations may exist between 40 and
100 per cent DAB. The anomaly in Fig. 2 and 3 that sharp eutectic points co-
exist with rather flat shoulders up to 60-70 per cent DAB or 3'-Me'DAB, may be
due to more stable molecular combinations by interaction between the phenolic hydroxyl in 4-hydroxyazobenzene and the basic nitrogen in the two aminoazo
dyes. In the phase diagram of 3'-Me-DAB plus 20-methyleholanthrene (Fig. 5)
a very noticeable polymorphic transformation has been observed at 10 per cent
3'-Me-DAB, in addition to an expected sharp eutectic point. The above phase diagrams recall the interesting work of Mtffler, G6rlich and
Kaliofer (1-954) who observed a correlation between mixed crystal formation in
binarv mixtures of polycyclic hydrocarbons and antagonism of these compounds
in epithelial careinogenesis. Applying the well known concept that for hetero-
genous organic catalysis a correlation of molecular geometry must exist between
the catalytic site and the organic substrate, these authors suggested that the
mixed crystal formation ofpolycyclic hydrocarbons may imply interchangeability
at celliilar receptor sites.
SUMMARY
1. There is synergism in hepatic tumor induction when a diet containing 0-04
per cent 2-Me-DAB plus 0-02 per cent 3'-Me-DAB is fed to rats. This synergism is
abolished by raising the concentration of 3'-Me-DAB to 0-035 per cent. Prolonged previousfeeding with 0
- 06 per cent 2-Me-DAB does not affect the tumor incidence
produced by a 0-054 per cent DAB diet.
2. Regions ofpolymorphic transformations that may be observed in the phase diagram of2-Me-DABplus 3'-Me-DAB suggestthat, inspite ofthe steric hindrance
present in the former compound, there is a close similarity in their spatial con-
figurations. For comparison, phase diagrams ofpairs of other azo dyes have been
determined.
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